Market Cap for Solventum (SOLV)
According to Solventum's latest reported financial statements, the company's latest reported market cap is $13.89B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
SOLV
Currently viewingMarket CapSwitch metric
Latest period
$13.89B
YoY change
-16.1%
5Y CAGR
N/A
Peak year (2025)
$13.89B
Latest annual
$11.66B
Market Cap history chart for Solventum (SOLV) from 2024 to 2026
Market Cap history table for Solventum (SOLV) from 2024 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $11.66B | -16.1% | ||
| 2025 | $13.89B | +21.1% | ||
| 2024 | $11.47B | — |
Market Cap values are taken from Solventum's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2026 reading of Solventum (SOLV) market cap is $11.66B – declined 16.1% year-over-year.
Solventum market cap peaked at $13.89B in 2025; the latest annual figure is $11.66B in 2026 (16.1% below peak).
Among 8 Healthcare peers, Solventum (SOLV) ranks 9th; the peer median for market cap is $311.16B.
Solventum Market Cap by Year
Solventum Market Cap 2026: $11.66B
Solventum market cap in 2026 was $11.66B, declined 16.1% below 2025.
Solventum Market Cap 2025: $13.89B
Solventum market cap in 2025 was $13.89B, grew 21.1% from 2024. This figure represents the highest annual value in the available history.
Solventum Market Cap 2024: $11.47B
Solventum market cap in 2024 was $11.47B.
See more financial history for Solventum (SOLV).
Sector peers — Market Cap
Companies in the same sector as Solventum, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Solventum's market cap?
- Latest reported market cap for Solventum (SOLV) is $13.89B (period ending December 31, 2025).
How has Solventum market cap changed year-over-year?
- Solventum (SOLV) market cap changed -16.1% year-over-year on the latest annual filing.
When did Solventum market cap hit its highest annual value?
- Solventum market cap reached its highest annual value of $13.89B in 2025.
What was Solventum market cap in 2025?
- Solventum (SOLV) market cap in 2025 was $13.89B.
What was Solventum market cap in 2026?
- Solventum (SOLV) market cap in 2026 was $11.66B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
SOLV Overview
Company profile, financial tools, and key metrics
SOLV Revenue Counter
Earns $263.98 every second. See per minute, hour, and day.
SOLV Earnings Counter
Earns $49.34 per second net profit. See per minute, hour, and day.
SOLV Economic Scale
Exceeds Montenegro's GDP. Compare with world economies.
SOLV What If Invested
What if you had invested $1,000? See historical returns from any date.
SOLV How It Makes Money
Discover visual breakdown of $8.32B in revenue — where it comes from and where it goes.
SOLV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
SOLV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
SOLV Daily Price Character
Steady · 48.6% historical win rate (green days). Streaks & record days.
SOLV Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.